WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H462447
CAS#: 1313730-14-1
Description: Teijin compound 1 is an antagonist of chemokine (C-C motif) receptor 2b (CCR2b).
Hodoodo Cat#: H462447
Name: Teijin Compound 1 HCl
CAS#: 1313730-14-1
Chemical Formula: C21H22Cl2F3N3O2
Exact Mass: 475.10
Molecular Weight: 476.321
Elemental Analysis: C, 52.95; H, 4.66; Cl, 14.88; F, 11.97; N, 8.82; O, 6.72
Related CAS #: 1313730-14-1
Synonym: Teijin Compound 1 HCl
IUPAC/Chemical Name: (R)-N-(2-((1-(4-chlorobenzyl)pyrrolidin-3-yl)amino)-2-oxoethyl)-3-(trifluoromethyl)benzamide hydrochloride
InChi Key: PGUQBBISBKGQDC-GMUIIQOCSA-N
InChi Code: InChI=1S/C21H21ClF3N3O2.ClH/c22-17-6-4-14(5-7-17)12-28-9-8-18(13-28)27-19(29)11-26-20(30)15-2-1-3-16(10-15)21(23,24)25;/h1-7,10,18H,8-9,11-13H2,(H,26,30)(H,27,29);1H/t18-;/m1./s1
SMILES Code: O=C(CNC(C1=CC(C(F)(F)F)=CC=C1)=O)N[C@@H]2CCN(CC3=CC=C(Cl)C=C3)C2.Cl
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 476.32 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Moree, W.J., Kataoka, K.-i., Ramirez-Weinhouse, M.M., et al. Small molecule antagonists of the CCR2b receptor. Part 2: Discovery process and initial structure-activity relationships of diamine derivatives. Bioorg. Med. Chem. Lett. 14(21), 5413-5416 (2004).
2: Hall, S.E., Mao, A., Nicolaidou, V., et al. Elucidation of binding sites of dual antagonists in the human chemokine receptors CCR2 and CCR5. Mol. Pharmacol. 75(6), 1325-1336 (2009).